E-LIB Suche - Ergebnisse für: N. K. Chernikova

1

Using the vaccinia virus MVA strain for developing recombin..:

Stovba, L. F. ; Krotkov, V. T. ; Melnikov, S. A....
Journal of microbiology, epidemiology and immunobiology. 98 (2021) 5 - p. 579-587 , 2021

Link: https://doi.org/10.36233..

2

An experience in the clinical use of specific immunoglobuli..:

Borisevich, I. V. ; Chernikova, N. K. ; Markov, V. I....
Problems of Virology. 62 (2017) 1 - p. 25-29 , 2017

Link: https://doi.org/10.18821..

3

Economics of electric heating in glass container factories:

Berezhkovskaya, M. I. ; Chernikova, N. K.
Glass and Ceramics. 24 (1967) 9 - p. 519-522 , 1967

Link: https://doi.org/10.1007/..

4

The pharmacogenetics of hypoglycemia and the glycemic varia..:

Chernikova, N. A. ; Kamynina, L. L. ; Ametov, A. S....
Terapevticheskii arkhiv. 92 (2020) 10 - p. 54-62 , 2020

Link: https://doi.org/10.26442..

5

Sensitivity of nonstationary neutron spectra in lead to nuc..:

Romodanov, V. L. ; Sakharov, V. K. ; Chernikova, D. N.
Atomic Energy. 112 (2012) 4 - p. 281-287 , 2012

Link: https://doi.org/10.1007/..

6

Properties of radiation from portable pulsed neutron genera..:

Romodanov, V. L. ; Sakharov, V. K. ; Chernikova, D. N....
Atomic Energy. 111 (2011) 1 - p. 42-47 , 2011

Link: https://doi.org/10.1007/..

7

A method for decreasing the loading on scintillation channe..:

Romodanov, V. L. ; Sakharov, V. K. ; Chernikova, D. N.
Instruments and Experimental Techniques. 53 (2010) 3 - p. 362-367 , 2010

Link: https://doi.org/10.1134/..

8

Comparison of the Efficacy of Different Schemes for Using R..:

L. F. Stovba ; O. V. Chukhralya ; D. I. Pavel'ev...
https://journal.microbe.ru/jour/article/view/1893/1428. , 2024

Link: https://journal.microbe...

9

Comparison of the Efficacy of Different Schemes for Using R..:

L. F. Stovba ; O. V. Chukhralya ; D. I. Pavel'ev..
https://journal.microbe.ru/jour/article/view/1893. , 2024

Link: https://doi.org/10.21055..

10

Safety and immunogenicity of IMVAMUNE®, a third-generation ..:

L. F. Stovba ; O. V. Chukhralya ; N. K. Chernikova...
https://www.biopreparations.ru/jour/article/view/447/625. , 2023

Link: https://www.biopreparati..

11

Safety and immunogenicity of IMVAMUNE®, a third-generation ..:

L. F. Stovba ; O. V. Chukhralya ; N. K. Chernikova..
https://www.biopreparations.ru/jour/article/view/447. , 2023

Link: https://doi.org/10.30895..

12

The Results of Clinical Trials of Recombinant Vaccine Virus..:

L. F. Stovba ; S. A. Mel'nikov ; D. I. Paveli'ev...
https://journal.microbe.ru/jour/article/view/1543. , 2021

Link: https://doi.org/10.21055..

13

The Results of Clinical Trials of Recombinant Vaccine Virus..:

L. F. Stovba ; S. A. Mel'nikov ; D. I. Paveli'ev...
https://journal.microbe.ru/jour/article/view/1543/1228. , 2021

Link: https://journal.microbe...

14

Using the vaccinia virus MVA strain for developing recombin..:

L. F. Stovba ; V. T. Krotkov ; S. A. Melnikov...
https://microbiol.elpub.ru/jour/article/view/1108. , 2021

Link: https://doi.org/10.36233..

15

Properties of Heterologous anti-Ebola Immunoglobulin after ..:

S. A. Melnikov ; I. V. Borisevich ; E. V. Rozhdestvensky...
https://www.biopreparations.ru/jour/article/view/215. , 2020

Link: https://doi.org/10.30895..